Disclosure of interests
HT and J-HL report being investigators of an ongoing multicenter trial regarding SLNB in cervical cancer (CSEM 010, NCT02642471) funded by a government project (Health and Medical Cooperation Innovation Special Program of Guangzhou Municipal Science and Technology, grant number: 158100075). J-HL receives lecture fees from AstraZeneca and Roche, outside the submitted work. All other authors declare no competing interests.